REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 310 filers reported holding REPLIGEN CORP in Q1 2020. The put-call ratio across all filers is 1.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,350,466 | +105.9% | 77,671 | +83.2% | 0.03% | +72.2% |
| Q2 2023 | $5,997,055 | +227.0% | 42,394 | +289.2% | 0.02% | +157.1% |
| Q1 2023 | $1,833,945 | +790.3% | 10,893 | +891.2% | 0.01% | +600.0% |
| Q3 2022 | $206,000 | -90.7% | 1,099 | -90.5% | 0.00% | -93.8% |
| Q4 2020 | $2,208,000 | +75.0% | 11,521 | +34.7% | 0.02% | -5.9% |
| Q3 2020 | $1,262,000 | -62.1% | 8,554 | -68.3% | 0.02% | -68.5% |
| Q2 2020 | $3,330,000 | +38.8% | 26,942 | +8.4% | 0.05% | -11.5% |
| Q1 2020 | $2,399,000 | +117.1% | 24,852 | +108.0% | 0.06% | +771.4% |
| Q4 2019 | $1,105,000 | +108.9% | 11,950 | +73.3% | 0.01% | +40.0% |
| Q3 2019 | $529,000 | +92.4% | 6,896 | +48.3% | 0.01% | +66.7% |
| Q1 2019 | $275,000 | -66.2% | 4,650 | -79.3% | 0.00% | -76.9% |
| Q1 2018 | $814,000 | +72.1% | 22,500 | +72.5% | 0.01% | +62.5% |
| Q4 2017 | $473,000 | -32.4% | 13,044 | -28.6% | 0.01% | -38.5% |
| Q3 2017 | $700,000 | – | 18,266 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
| Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
| Miura Global Management | 85,000 | $24,564,000 | 3.81% |
| Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
| Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
| AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
| Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
| Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
| Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
| SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |